AI Governance Institute
← All news

US AI Regulation

The United States has no single federal AI law. Instead, AI oversight is split across federal agencies acting under existing authority and a fast-growing patchwork of state legislation. The FTC uses consumer protection law to challenge deceptive AI claims. The SEC requires disclosure of material AI risk. The FDA regulates AI as a medical device. Executive orders have set and then reversed federal AI priorities across administrations.

State legislation is where the concrete compliance obligations are landing first. Colorado's AI Act, California's AI Transparency Act, Illinois' Biometric Information Privacy Act (BIPA), and New York City's Local Law 144 each impose real requirements on organizations deploying AI that affects consumers, employees, or residents of those states. For a multi-state employer or platform, this means tracking a moving target across dozens of legislatures rather than a single statute.

This hub tracks federal agency enforcement, state AI legislation, and the executive-branch policy shifts that define the US AI regulatory landscape as it develops.

181 items

ResearchUS2026-05-03

Anthropic's Safety Board Structure Among Frontier AI Governance Mechanisms Analyzed in Harvard Law Review

A March 2026 Harvard Law Review article examines how frontier AI companies such as OpenAI. Anthropic have adopted governance structures designed to counterbalance commercial profit pressures with safety-oriented accountability. The analysis focuses in particular on Anthropic's charter mechanism. Which grants Class T shareholders the right to elect three of five board directors either after May 24, 2027. Eight months following the receipt of $6 billion in investment capital, whichever occurs first. These trustees are empowered to prioritize safety considerations, structurally limiting the influence of purely profit-driven incentives at the board level. The research classifies these arrangements as prosocial corporate governance tools. Situates them within broader stakeholder-focused approaches to managing AI development risks. For enterprise compliance teams, the analysis provides a framework. Evaluating whether AI vendors' internal governance structures credibly constrain high-risk development practices. Which is increasingly relevant to third-party risk assessments and AI procurement due diligence. While the article is not a binding instrument, its articulation of concrete governance benchmarks offers practical reference points. Assessing AI suppliers against emerging standards.